Anucleated live e. coli vaccine

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/135, 195/49

C12N 15/00 (2006.01) A61K 39/02 (2006.01) A61K 39/108 (2006.01)

Patent

CA 1146882

ABSTRACT OF THE DISCLOSURE An E. coil strain producing metabolically active but non-reproductive, anucleated live cells, which contain the K99 surface antigen, is obtained by transferring the K99 plasmid from a K99+ entero pathogenic E. coli strain into an E. coli strain which generates progeny of cells that lack the ability to multiply. From the resulting E. coli strain a "live" vaccine is prepared. Separation and purification of the anucleated live cells from growing cells is the basis for the "live" and chemically and/or physically unmodified vaccine. The vaccine induces the production of antibodies against growing and infective enteropathogenic K99+ E. coli in cattle and is, thus effective against coliform enteritis.

350748

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anucleated live e. coli vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anucleated live e. coli vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anucleated live e. coli vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-853114

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.